Anti-wrinkle treatments
Anti-wrinkle treatment aftercare: what is normal and when to seek help
Good aftercare separates sensible precautions from rigid rules, explains expected short-term reactions and gives every patient a clear route to help if concerning symptoms develop.
Aftercare should be explained before treatment
Aftercare is not simply a list handed over after an injection. Before treatment, the practitioner should explain likely short-term reactions, when change may become visible, what limitations apply and how to obtain advice outside normal opening hours. The patient should also know what was administered and where, so another clinician can understand the treatment if help is needed.
Suitability still comes first. Medical history, medicines, allergies, previous reactions, pregnancy or breastfeeding, swallowing or breathing problems, neuromuscular conditions, active skin infection and planned procedures may alter the risk or mean treatment should be postponed. A photograph or online message cannot replace an individual consultation and physical assessment.
What may happen during the first day?
Small raised points, redness, tenderness or minor bruising can occur where the needle entered. Some people experience a temporary headache. These effects do not predict the final result and commonly settle, but the pattern and severity matter. Increasing pain, spreading redness, heat, discharge, fever or rapidly worsening swelling should not be dismissed as routine downtime.
Avoid rubbing, pressing or deliberately massaging the treated areas unless the practitioner specifically advises it. Use gentle skincare and follow the written instructions supplied for the exact treatment. If makeup is used after the skin has settled, clean hands and clean applicators are sensible because the injection sites have briefly interrupted the skin barrier.
Do you need a long list of restrictions?
Advice to remain upright, avoid bending, stop exercise or restrict facial movement for many hours is widely repeated. A 2025 retrospective study reviewed more than 5,000 upper-face treatments across six centres where patients followed only a ten-minute precaution period. It did not find that extended restrictions were needed for good short-term outcomes.
However, the study had no comparison group, looked back at existing records and assessed patients at two weeks. It cannot prove that every restriction is unnecessary for every patient, injection site or product. The practical conclusion is not to ignore aftercare, but to avoid presenting unsupported rules as guarantees. Follow the individual practitioner's instructions and ask when the reason is unclear.
Results should not be judged too early
Anti-wrinkle treatment does not produce its finished effect immediately. Early asymmetry can reflect swelling, different muscle strength or one side settling before the other. Repeated mirror checking on the first few days can create unnecessary concern, while treating again too soon may increase the risk of unwanted weakness or an unnatural result.
The review timing should be agreed at consultation. Standardised photographs at rest and during expression are more useful than images taken under different lighting or camera angles. At review, the practitioner should compare the result with the original goal, examine facial movement and decide whether observation, adjustment or no further treatment is the safest option.
Know the difference between review and emergency
A heavy brow, eyelid droop, altered smile or unexpected asymmetry needs prompt contact with the treating clinician for assessment. These problems may be distressing even when not medically urgent. Patients should not seek correction from several providers at once, as fragmented care can make the cause and the safest next step harder to establish.
Difficulty swallowing, slurred speech, breathing difficulty or widespread muscle weakness requires immediate medical attention. The MHRA advised in July 2026 that rare serious symptoms may typically begin four to eight days after treatment and can appear up to four weeks later. This is why safety-netting must extend beyond the day of the appointment.
Follow-up is part of responsible treatment
The General Medical Council requires practitioners to explain monitoring and follow-up requirements and to provide a route to a suitably qualified person if complications occur outside normal hours. A patient should leave knowing which number to use, what information to give and when not to wait for a routine appointment.
Suspected side effects can also be reported to the MHRA Yellow Card scheme by patients or healthcare professionals. Reporting does not replace clinical care: anyone who is unwell should seek medical advice first. Balanced aftercare supports recovery without promising that following every instruction will prevent all adverse effects or guarantee a particular cosmetic result.